Melarsoprol

Melarsoprol is a member of triazines. Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis). Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects. It is grouped under the following drug class(es): Trypanosomiasis agents. Its therapeutic use is listed as antiparasitics and antiprotozoals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mel B and Melarsoprolum. Its PubChem CID is 10311.

CAS No 494-79-1
Molecular Formula C12H15AsN6OS2
Molecular Weight 398.3 g/mol
Synonyms [2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol

Frequently Asked Questions